Romidepsin Is Effective and Well-Tolerated In Patients ≥ 60 Years Old With Relapsed Or Refractory Peripheral T-Cell Lymphoma (PTCL): Analysis From Phase 2 Trials

被引：1
|
作者：
Shustov, Andrei R.
Coiffier, Bertrand
Horwitz, Steven M.
Sokol, Lubomir
Pro, Barbara
Nielsen, Tina
Wolfson, Julie
Balser, Barbara E.
Eisch, Robin
Popplewell, Leslie
Prince, Miles
Allen, Steven L.
Piekarz, Richard
Bates, Susan E.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Bennani, N. Nora
    Pederson, Levi D.
    Atherton, Pamela
    Micallef, Ivana
    Colgan, Joseph P.
    Thanarajasingam, Gita
    Nowakowski, Grzegorz
    Witzig, Thomas E.
    Feldman, Andrew L.
    Ansell, Stephen M.
    BLOOD, 2019, 134
  • [42] Multicenter phase II study of romidepsin plus lenalidomide for patients with previously untreated peripheral T-cell lymphoma (PTCL).
    Ruan, Jia
    Zain, Jasmine M.
    Palmer, Brett
    Jovanovic, Borko
    Mi, Xinlei
    Swaroop, Alok
    Winter, Jane
    Gordon, Leo I.
    Karmali, Reem
    Pro, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] A Phase Ib Study of Linperlisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Jin, Jie
    Cen, Hong
    Zhou, Keshu
    Xu, Xiaohong
    Li, Fei
    Yang, Haiyan
    Li, Zhiming
    Bao, Hanying
    Xu, Zusheng
    Qiu, Lugui
    Shu, Yang
    Li, Fei
    Wang, Zhen
    BLOOD, 2021, 138
  • [44] Use of Brentuximab-ICE and Romidepsin-ICE in Relapsed/Refractory Peripheral T-Cell Lymphoma
    Gentille, Cesar
    Sarfraz, Humaira
    Randhawa, Jasleen
    Shah, Shilpan
    Pingali, Sai Ravi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S257 - S257
  • [45] Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
    Kim, Won-Seog
    Fukuhara, Noriko
    Yoon, Dok-Hyun
    Yamamoto, Kazuhito
    Uchida, Toshiki
    Negoro, Eiju
    Izutsu, Koji
    Terui, Yasuhito
    Nakajima, Hideaki
    Ando, Kiyoshi
    Suehiro, Youko
    Kang, Hye Jin
    Ko, Po-Shen
    Nagahama, Fumiko
    Sonehara, Yusuke
    Nagai, Hirokazu
    Tien, Hwei-Fang
    Kwong, Yok-Lam
    Tobinai, Kensei
    BLOOD ADVANCES, 2023, 7 (17) : 4903 - 4912
  • [46] Romidepsin Induces Durable Responses in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)
    Pro, Barbara
    Horwitz, Steven M.
    Prince, H. Miles
    Foss, Francine M.
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Iyer, Swaminathan Padmanabhan
    Malignancies, Hematological
    Shustov, Andrei R.
    Wolfson, Julie
    Balser, Barbara E.
    Coiffier, Bertrand
    BLOOD, 2014, 124 (21)
  • [47] Phase II Study of the Fondazione Italiana Linfomi on Gemcitabine Plus Romidepsin (GEMRO Regimen) in Relapsed and Refractory Peripheral T-Cell Lymphoma Patients
    Pellegrini, Cinzia
    Broccoli, Alessandro
    Casadei, Beatrice
    Chiappella, Annalisa
    Corradini, Paolo
    Derenzini, Enrico
    Dodero, Anna
    Farina, Lucia
    Gandolfi, Letizia
    Ladetto, Marco
    Monaco, Federico
    Orsucci, Lorella
    Quirini, Federica
    Salvi, Flavia
    Spina, Francesco
    Stefoni, Vittorio
    Tonialini, Lorenzo
    Vitolo, Umberto
    Argnani, Lisa
    Zinzani, Pier Luigi
    BLOOD, 2015, 126 (23)
  • [48] Final Analysis of the RO-CHOP Phase Ib/II Study: Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphoma (PTCL)
    Dupuis, Jehan
    Morschhauser, Franck
    Ghesquieres, Herve
    Tilly, Herve
    Casasnovas, Olivier
    Amorim, Sandy
    Ribrag, Vincent
    Coiffier, Bertrand
    BLOOD, 2014, 124 (21)
  • [49] A Phase Ib Trial of Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphoma (PTCL): The Ro-CHOP Study
    Dupuis, Jehan
    Casasnovas, Rene-Olivier
    Ghesquieres, Herve
    Morschhauser, Franck
    Tilly, Herve
    Thieblemont, Catherine
    Ribrag, Vincent
    Coiffier, Bertrand
    BLOOD, 2012, 120 (21)
  • [50] Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
    Mridula Krishnan
    R. Gregory Bociek
    Michelle Fanale
    Swaminathan P. Iyer
    Mary Jo Lechowicz
    Philip J. Bierman
    James O. Armitage
    Matthew Lunning
    Avyakta Kallam
    Julie M. Vose
    Annals of Hematology, 2022, 101 : 335 - 340
12345